New Study May Impact Hernia Mesh Claims
Hernia mesh is a medical device commonly placed by surgeons in the area around a hernia in order to support damaged tissue during the healing process. Nine out of 10 hernia surgeries each year involves the mesh. Unfortunately, complications such as bowel obstructions and perforation, sometimes do arise once the mesh is placed, and patients may need additional surgery to remove the mesh, as well as extensive medical care when that happens. A recent study asked whether synthetic mesh is better than biologic mesh at reducing a 2-year risk of hernia recurrence when a single stage repair of ventral hernias is made. The findings tend to support the use of synthetic mesh rather than biologic hernia mesh because synthetic mesh entails lower costs and recurrences. If you were injured by hernia mesh, you should call the seasoned Chicago product liability lawyers of Moll Law Group. Billions have been recovered in cases with which we’ve been involved.
Give Moll Law Group a Call About Your Hernia Mesh Claim
Injured consumers have filed at least 14,827 lawsuits against Bard and 3596 lawsuits against Ethicon. They are consolidated in multidistrict litigation. In the recent study, a multicenter randomized clinical trial, 253 patients were randomized to synthetic mesh and biologic mesh. At two years, the follow-up rate was 92%. Synthetic mesh majorly reduced the risk of hernia recurrence and did more in that regard than biologic mesh when a patient was going through single stage repair of ventral hernias.
The study noted that biologic mesh is usually used to reinforce contaminated ventral hernia repairs but is expensive and associated with high rates of long-term recurrence of hernias. Synthetic mesh costs less and may be able to do the same thing, but its efficacy in contaminated hernia cases hadn’t previously been subjected to rigorous study.